Evidence map›Paper›PMID 41256833›Full record

ArticleFrontiers in surgery2025

Development and validation of a practical prediction model for post-ERCP pancreatitis using machine learning.

Tianyu De, Guohui Du, Hongkun Yin, Hao Wang, Wei Wang, Tian Ma, Junbai Ma, Hao Wang, Qi Wang

Abstract read
In one paragraph

Article in Frontiers in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tianyu DeDepartment of Hepatobiliary Surgery, General Hospital of Ningxia Medical University, Yinchuan, China.
Guohui DuSchool of Clinical Medicine, General Hospital of Ningxia Medical University, Yinchuan, China.
Hongkun YinSchool of Clinical Medicine, General Hospital of Ningxia Medical University, Yinchuan, China.
Hao WangSchool of Clinical Medicine, General Hospital of Ningxia Medical University, Yinchuan, China.
Wei WangNeonatal Intensive Care, General Hospital of Ningxia Medical University, Yinchuan, China.
Tian MaDepartment of Thoracic and Cardiovascular Surgery, General Hospital of Ningxia Medical University, Yinchuan, China.
Junbai MaSchool of Basic Medical Sciences, Ningxia Medical University, Yinchuan, China.
Hao WangDepartment of Pathogenic Biology and Medical Immunology, School of Basic Medical Sciences, Ningxia Medical University, Yinchuan, China.
Qi WangDepartment of Hepatobiliary Surgery, General Hospital of Ningxia Medical University, Yinchuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) is one most frequent and severe complication of ERCP. In consideration of recent advancements in both endoscopic and artificial intelligence research, it is possible to construct a practical risk prediction model to facilitate the identification of PEP patients at elevated risk. Aim: We developed and validated a concise predictive model for post-ERCP pancreatitis risk with logistic regression (LR), LightGBM, Support Vector Machine (SVM), XGBoost, and Multilayer Perceptron (MLP) neural network models. Methods: We selected 688 patients undergone ERCP to form the basic dataset, with 70% for training and 30% for validation. Subsequently, Stepwise Backward Selection Based on Logistic Regression was utilized to select pertinent clinical features, incorporating the machine learning (ML) models to construct the final predictive model. The efficacy of the model was evaluated by various metrics. These newly identified clinical features were then incorporated into a simplified, points-based risk scoring system for potential bedside application and further evaluation. Results: Based on the collected data and the results of stepwise backward regression, we identified the following features as potentially significant clinical variables that influence the risk of post-ERCP pancreatitis: periampullary diverticulum, pancreatic stent placement, pancreatic guidewire passages, dilation of the extrahepatic bile duct, age, and coronary artery disease, and constructed a prediction model. Following this, several ML models were constructed to assess the performance of this model. All ML models demonstrated superior performance to conventional logistic regression (LR) models in terms of AUC curves, with XGBoost, SVM, LightGBM, and MLP models all achieving at least acceptable performance levels. Finally, we developed a simplified scoring system based on LightGBM model with an AUC of 0.75. Conclusions: We developed and validated a concise predictive model for post-ERCP pancreatitis risk, and a simplified scoring system based on the LightGBM model. This model facilitates individual risk prediction and preventive strategy selection.

Indexed as

artificial intelligencemachine learningpost-ERCP pancreatitispredictive modelrisk prediction

Identifiers

PMID41256833
PMCPMC12620498

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.